Article
Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience.
The oncologist - 1 Dec 2020
Bonanno Laura, Pavan Alberto, Ferro Alessandra, Calvetti Lorenzo, Frega Stefano, Pasello Giulia, Aprile Giuseppe, Guarneri Valentina, Conte PierFranco
Abstract excerpt
BACKGROUND: Targeted agents have improved the outcome of a subset of non-small cell lung cancer (NSCLC). Molecular profiling by next-generation sequencing (NGS) allows screening for multiple genetic alterations both in tissue and in plasma, but limited data are available concerning its feasibility and impact in real-world clinical practice. METHODS: Patients with advanced NSCLC consecutively referring to our...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
